Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phreesia (PHR) Cash & Equivalents (2018 - 2025)

Historic Cash & Equivalents for Phreesia (PHR) over the last 8 years, with Q4 2025 value amounting to $106.4 million.

  • Phreesia's Cash & Equivalents rose 3013.33% to $106.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $106.4 million, marking a year-over-year increase of 3013.33%. This contributed to the annual value of $84.2 million for FY2025, which is 377.06% down from last year.
  • Per Phreesia's latest filing, its Cash & Equivalents stood at $106.4 million for Q4 2025, which was up 3013.33% from $98.3 million recorded in Q3 2025.
  • Phreesia's Cash & Equivalents' 5-year high stood at $450.7 million during Q2 2021, with a 5-year trough of $79.5 million in Q2 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $138.7 million (2023), whereas its average is $190.5 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first surged by 42239.81% in 2021, then tumbled by 5068.16% in 2023.
  • Quarter analysis of 5 years shows Phreesia's Cash & Equivalents stood at $400.4 million in 2021, then crashed by 47.65% to $209.6 million in 2022, then tumbled by 50.68% to $103.4 million in 2023, then decreased by 20.92% to $81.7 million in 2024, then skyrocketed by 30.13% to $106.4 million in 2025.
  • Its Cash & Equivalents stands at $106.4 million for Q4 2025, versus $98.3 million for Q3 2025 and $90.9 million for Q2 2025.